Bestatin Analogue from Streptomyces neyagawaensisSL-387

Bioscience, Biotechnology and Biochemistry

Volumn 60, Issue 5, 1996, Pages 898-900

  Chung, Myung Chul ^a   Lee, Ho Jae ^a   Chun, Hyo Kon ^a   Lee, Choong Hwan ^a   Kim, Su II ^b   Kho, Yung Hee ^a  

^a Applied Microbiology Research Group   (Japan)

^b Seoul National University   (South Korea)

Author keywords

Aminopeptidasen; Bestatin analogue; Inhibitor

Indexed keywords

AMINO ACID; AMINOPEPTIDASE; APSTATIN; BESTATIN; DRUG DERIVATIVE; LEUCINE; MICROSOMAL AMINOPEPTIDASE; MR 387A; OLIGOPEPTIDE; PEPTIDE; PROTEINASE INHIBITOR; VALINE;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STREPTOMYCES;

AMINO ACIDS; AMINOPEPTIDASES; ANTIGENS, CD13; HUMANS; LEUCINE; MAGNETIC RESONANCE SPECTROSCOPY; OLIGOPEPTIDES; PEPTIDES; PROTEASE INHIBITORS; STREPTOMYCES; VALINE;

STREPTOMYCES; STREPTOMYCES NEYAGAWAENSIS; SUIDAE;

EID: 0030151803     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60.898     Document Type: Article

References (15)

1. H. Umezawa, T. Aoyagi, H. Suda, M. Hamada, and T. Takeuchi, J. Antibiotics, 29, 97-100 (1976).
2. D. H. Rich, B. J. Moon, and S. Harbeson, J. Med. Chem., 27.417-422 (1984).
3. H. Umezawa, M. Ishizuka, T. Aoyagi, and T. Takeuchi. J. Antibiotics, 29, 857-859 (1976).
4. H. Kuramochi, A. Motegi, M. Iwabuchi, A. Takahashi, H. Horinishi, and H. Umezawa, J. Antibiotics, 40, 1065-1611 (1987).
5. F. Abe, K. Shibuya, M. Uchida, K. Takahashi, H. Horinishi, A. Matsuda, M. Ishizuka, T. Takeuchi, and H. Umezawa, Gann, 75, 89-94 (1984).
6. H. U. Schorlemmer, K. Bosslet, and H. H. Sedlacek, Cancer Res., 43, 4148—4153 (1983).
7. M. Ishizuka, T. Aoyagi, T. Takeuchi, and H. Umezawa, in "Small Molecular Immunomodifiers of Microbial Origin: Fundamental and Clinical Studies of Bestatin,” Japan Scientific Societies Press, Tokyo, 1981, pp. 17-38.
8. I. Saiki, H. Fujii, J. Yoneda, F. Abe, M. Nakajima, T. Tsuro, and I. Azuma, Int. J. Cancer, 54, 137-143 (1993).
9. A. Menrad, D. Speicher, J. Wacker, and M. Herlyn, Cancer Res., 53, 1450-1455 (1993).
10. M. C. Chung, H. K. Chun, K. H. Han, H. J. Lee, C. H. Lee, and Y. H. Kho, J. Antibiotics, 49, 99-102 (1996).
11. R. Nishizawa, T. Saino, T. Takia, H. Suda, T. Aoyagi, and H. Umezawa, J. Med. Chem., 20, 510-515 (1977).
12. M. C. Chung, D. J. Park, C. J. Kim, S. I. Kim, and Y. H. Kho, Agric. Chem. Biotechnol. (in Korean), 38, 196-201 (1995).
13. H. Umezawa, T. Aoyagi, T. Tanaka, H. Suda, A. Okuyama, H. Naganawa, M. Hamada, and T. Takeuchi, J. Antibiotics. 38, 1629-1630 (1985).
14. T. Nishikiori, H. Naganawa, Y. Muraoka, T. Aoyagi, and H. Umezawa, J. Antibiotics, 39, 745-754 (1986).
15. K. Ino, S. Goto, T. Okamoto, S. Nomura, A. Nawa, K. Isobe, S. Mizutani, and Y. Tomoda, Jpn. J. Cancer Res., 85, 927-933 (1994).